
CRIS
Healthcare · Biotechnology · $3.0M market cap
$0.4450-0.13 (-22.2%)Nov 13, 4:29 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +72.6% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 12, 2026 | After the close | -2.29 | -1.94 | +15.3% |
| Aug 14, 2026 | After the close | -5.70 | -4.02 | +29.5% |
| May 12, 2026 | After the close | -5.80 | -25.00 | -331.0% |
| Mar 20, 2026 | Time not confirmed | -8.65 | -9.95 | -15.0% |
| Nov 6, 2025 | After the close | -12.00 | -9.80 | +18.3% |
| Aug 5, 2025 | Before the open | -30.30 | -13.60 | +55.1% |
| May 6, 2025 | Before the open | -25.27 | -25.00 | +1.1% |
| Mar 31, 2025 | Time not confirmed | -0.99 | -1.25 | -26.3% |
| Nov 14, 2024 | Before the open | -38.16 | -34.00 | +10.9% |
| Aug 1, 2024 | Before the open | -36.20 | -40.60 | -12.2% |
| May 7, 2024 | Before the open | -42.44 | -41.00 | +3.4% |
| Feb 8, 2024 | Before the open | -43.93 | -40.60 | +7.6% |
| Nov 2, 2023 | Before the open | -47.15 |
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small-molecule IRAK4 kinase inhibitor, which is in a Phase 1/2 open-label, single-arm expansion trial in patients with relapsed/refractory primary central nervous system lymphoma. The company's…
| -42.60 |
| +9.7% |
| Aug 3, 2023 | After the close | -47.00 | -48.00 | -2.1% |
| May 4, 2023 | After the close | -43.00 | -48.00 | -11.6% |
| Mar 13, 2023 | Before the open | -0.13 | -0.12 | +7.7% |
| Nov 9, 2022 | After the close | -68.00 | -56.00 | +17.6% |
| Aug 4, 2022 | After the close | -66.00 | -68.00 | -3.0% |
| May 5, 2022 | After the close | -64.00 | -72.00 | -12.5% |
| Feb 24, 2022 | After the close | -0.13 | -0.15 | -15.4% |
| Nov 9, 2021 | After the close | -52.00 | -48.00 | +7.7% |
| Aug 3, 2021 | After the close | -44.00 | -48.00 | -9.1% |
| May 12, 2021 | After the close | -37.00 | -44.00 | -18.9% |
| Mar 16, 2021 | After the close | -0.09 | -0.11 | -22.2% |
| Nov 10, 2020 | After the close | -68.00 | -44.00 | +35.3% |
| Aug 4, 2020 | After the close | -80.00 | -68.00 | +15.0% |
| Jun 24, 2020 | After the close | — | -0.28 | — |
| Mar 19, 2020 | Time not confirmed | -0.20 | -5.20 | -2500.0% |
| Nov 5, 2019 | Time not confirmed | -0.20 | -3.80 | -1800.0% |
| Aug 6, 2019 | Time not confirmed | -0.19 | -4.40 | -2215.8% |
| May 14, 2019 | Time not confirmed | -0.19 | -6.00 | -3057.9% |
| Mar 26, 2019 | After the close | -84.00 | -72.00 | +14.3% |
| Nov 1, 2018 | Before the open | -122.67 | -88.00 | +28.3% |
| Aug 2, 2018 | Before the open | -153.33 | -104.00 | +32.2% |
| May 3, 2018 | Before the open | -140.00 | -140.00 | 0.0% |
| Mar 8, 2018 | Before the open | -0.45 | -0.25 | +44.4% |